Case Study | October 02, 2008 | Suhny Abbara, M.D., assistant professor, Harvard Medical School, director, Cardiovascular Imaging, M

Biphasic Injection Protocol – Optimized for Coronary Artery Imaging

Stock image

This case is a routine coronary CTA with the focus on the coronary arteries. The patient was a middle-aged male with a family history of coronary artery disease, moderate risk profile and atypical chest pain. The EKG did not indicate myocardial ischemia and there was no enzyme leak. The referring physician was considering invasive angiography to definitely exclude coronary artery disease as the cause of the atypical chest pain. Due to concerns regarding the invasiveness of the procedure and a relatively low likelihood that coronary artery disease was present, a cardiac gated 64-slice coronary MDCT angiogram was performed instead.
The contrast injection protocol in this study is tailored to opacify the coronary arteries during the MDCT acquisition and to wash out the right atrium and ventricle with a saline chaser bolus.
The latter is desired for two reasons. First, if contrast were to remain in the right heart during acquisition, streak artifact may result in image degradation, potentially decreasing the evaluability of the mid-RCA. The streak artifact occurs because of the mixing of relatively dense contrast containing blood from the superior vena cava with in-flowing, non-opacified blood from the inferior vena cava. Secondly, if contrast material is located in the right heart during the scan acquisition, it obviously cannot contribute to the opacification of the coronary arteries — the structures of interest. A higher contrast volume at a higher rate, therefore, would be necessary to achieve the same opacification as in a patient with washed out right heart and optimal contrast timing.
Because the image quality in this case is excellent and the negative predictive value of coronary CTA in research studies is typically between 95 and 100 percent, it could be established that in this patient the chest symptoms were unrelated to coronary artery disease. The patient was spared the invasive angiogram.

Related Content

Bayer Introduces Medrad Stellant Flex CT Injection System
Technology | Contrast Media Injectors | September 11, 2019
Bayer announced the introduction of the Medrad Stellant Flex computed tomography (CT) injection system. Stellant Flex...
Characteristics nephrologists associate with renal high-risk patients. (n=13)

Characteristics nephrologists associate with renal high-risk patients. (n=13)

Feature | Contrast Media | September 05, 2019
The global rise in chronic disease has significantly increased demand for diagnostic imaging procedures, and in turn,
News | Contrast Media | September 03, 2019
Researchers in South Korea have found that patients with family and personal history of allergic reactions to contrast...
Displacement comparison at the end-systolic frame and final frame

Displacement comparison at the end-systolic frame and final frame. The three patients (V6, V10, V16) with different left-ventricle walls are shown. Point-to-surface distance is a measure to estimate the distance of a point from the reference surface. Image courtesy of WMG, University of Warwick

News | Cardiac Imaging | August 28, 2019
A new 3-D magnetic resonance imaging (MRI) computing technique developed by scientists in WMG at the University of...
Some Pregnant Women Are Exposed to Gadolinium in Early Pregnancy
News | Women's Health | August 20, 2019
A small but concerning number of women are exposed to a commonly used magnetic resonance imaging (MRI) contrast agent...
Contrast Use in First Transthoracic Echocardiogram for Heart Failure Reduces Repeat Testing
News | Cardiovascular Ultrasound | August 07, 2019
Heart failure is the fourth most common cause for all admission to U.S. hospitals, and it is the most common reason for...
Bracco Receives FDA Approval for Varibar Thin Liquid for Oral Suspension
Technology | Contrast Media | August 05, 2019
Bracco Diagnostics Inc. announced U.S. Food and Drug Administration (FDA) approval for Varibar Thin Liquid (barium...
Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
ITN Wins Jesse H. Neal Award for Best Technical Content
News | Radiology Business | April 24, 2019
April 24, 2019 — Imaging Technology News (ITN) was recently named the 2019 Jesse H.